¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Menstrual Pain Relief Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â À̹ø¿¡ ¼¼°èÀÇ ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå¿¡ °üÇÑ Á¾ÇÕ º¸°í¼¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÃËÁø¿äÀΡ¤µ¿Ç⡤±âȸ¡¤°úÁ¦¸¦ Æ÷ÇÔÇÑ Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» öÀúÇÏ°Ô Æò°¡Çϰí, ½ÃÀå ±¸Á¶¿¡ °üÇÑ »ó¼¼ÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå ±Ô¸ð(2024³â) : 105¾ï ´Þ·¯
¿¹Ãø ½ÃÀå ±Ý¾×(2031³â) : 188¾ï ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024-2031³â) : 8.6%
¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå : Á¶»ç ¹üÀ§
¿ù°æÅë ¿ÏÈ ±â±â´Â ¿ù°æ°ú °ü·ÃµÈ ºÒÆíÇÔÀ» ¿ÏÈÇϱâ À§ÇØ °í¾ÈµÈ °ÍÀ¸·Î, ¿Â¿ ÆÐµå¿Í TENS(°æÇÇÀû Àü±â½Å°æÀÚ±Ø) ÀåºñºÎÅÍ ¿þ¾î·¯ºí ±â±â ¹× Çõ½ÅÀûÀÎ ±â¼ú ±â¹Ý ¼Ö·ç¼Ç¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ±â±âµéÀº ¿ù°æÅë ¹× ±âŸ »ý¸® °ü·Ã ÅëÁõÀ¸·Î °íÅë¹Þ´Â »ç¶÷µéÀÇ ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ °¡Á¤°ú ÀÓ»ó ¸ðµÎ¿¡¼ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.
»ý¸® °Ç°¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ºñ¾à¸®ÇÐÀû ÅëÁõ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, »ç¿ëÀÚ ÆíÀǼº°ú È¿°ú¼ºÀ» Çâ»ó½ÃŰ´Â ±â±â ±â¼úÀÇ ¹ßÀüÀÌ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº »ý¸®ÅëÀ» °æÇèÇÏ´Â ¸ðµç ¿¬·É´ëÀÇ ¿©¼ºÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ¿¬·É´ëÀÇ ¿©¼ºÀ» ´ë»óÀ¸·Î Çϸç, »îÀÇ Áú Çâ»ó°ú ¾à¹° ÀÇÁ¸µµ °¨¼Ò¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.
½ÃÀå ¼ºÀåÀÇ ÃËÁø¿äÀÎ:
´ë¾ÈÀû ÅëÁõ ¿ÏÈ ¹æ¹ý¿¡ ´ëÇÑ ¼ÒºñÀÚ ÀÎ½Ä Áõ°¡, ¿©¼ºÀÇ »ý¸®Åë À¯º´·ü Áõ°¡, ºñħ½ÀÀû Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀÎÀÌ ¼¼°è »ý¸®Åë ¿ÏÈ ±â±â ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½º¸¶Æ® ¿Â¿ ÆÐµå, ¾ÛÀÌ ÅëÇÕµÈ TENS Àåºñ µî ±â¼úÀûÀ¸·Î Áøº¸µÈ ±â±â ½ÃÀå °³Ã´Àº ±â´É¼º°ú »ç¿ëÀÚ °æÇèÀ» Çâ»ó½ÃÄÑ ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ »ý¸®Åë °ü¸®¸¦ À§ÇØ °³ÀÎÈµÇ°í Æí¸®ÇÑ ¼Ö·ç¼ÇÀ» ã´Â °³ÀÎÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼¿ÇÁ ÄÉ¾î ¹× À£´Ï½º Á¦Ç° äÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :
¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀåÀº À¯¸ÁÇÑ ¼ºÀå ÀáÀç·ÂÀ» °¡Áö°í ÀÖÁö¸¸, °¡°Ý ºÎ´ã, È¿°ú¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ È¸ÀÇÀûÀÎ ½Ã°¢, ÀϺΠÁö¿ª¿¡¼ÀÇ ³·Àº ÀÎÁöµµ µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÷´Ü »ý¸®Åë ¿ÏÈ ±â±â´Â °í°¡À̱⠶§¹®¿¡ ƯÈ÷ ÀÇ·á ¿¹»êÀÌ ÀûÀº ½ÅÈï ½ÃÀå¿¡¼´Â »ç¿ëÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â±âÀÇ È¿°ú¿Í ¾ÈÀü¼º¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀÎ½Ä Â÷À̵µ ½ÃÀå µµÀÔ¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ À庮À» ±Øº¹Çϱâ À§Çؼ´Â Ÿ±êÆÃµÈ ±³À° Ä·ÆäÀΰú ±â±âÀÇ ±¸¸Å ¿ëÀ̼º ¹× Á¢±Ù¼ºÀ» °³¼±Çϱâ À§ÇÑ ³ë·ÂÀÌ ÇÊ¿äÇÕ´Ï´Ù.
½ÃÀå ±âȸ :
¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀåÀº ±â¼ú Çõ½Å, ¼ÒºñÀÚ ¼±È£µµÀÇ ÁøÈ, À¯Åë ä³ÎÀÇ È®´ë·Î ÀÎÇØ Å« ¼ºÀå ±âȸ¸¦ ¸ÂÀÌÇϰí ÀÖ½À´Ï´Ù. ÅëÁõ ÃßÀû ¹× °³ÀÎÈµÈ ÃßõÀ» À§ÇÑ ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ǰú °°Àº µðÁöÅÐ °Ç° ±â¼úÀÇ ÅëÇÕÀº »ç¿ëÀÚ Âü¿©¿Í Ä¡·á °á°ú¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿©¼º °Ç°°ú À£ºù¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ½ÃÀå Âü¿©Àڵ鿡°Ô »õ·Ó°í °³¼±µÈ ±â±â¸¦ µµÀÔÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù. R&D¿¡ ´ëÇÑ Àü·«Àû ÅõÀÚ, ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿ÍÀÇ Á¦ÈÞ, »õ·Î¿î Áö¿ªÀ¸·ÎÀÇ ÁøÃâÀº »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇÏ°í ½ÃÀå ¸®´õ½ÊÀ» À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ ´Ù·é ÁÖ¿ä Áú¹®
¼¼°è ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
´Ù¾çÇÑ °èÃþ¿¡¼ ½ÃÀå µµÀÔÀ» ÃËÁøÇÏ´Â Àåºñ À¯Çü°ú ±â¼úÀº ¹«¾ùÀΰ¡?
±â¼úÀÇ ¹ßÀüÀº ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå °æÀï ±¸µµ¸¦ ¾î¶»°Ô º¯È½Ã۰í Àִ°¡?
¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ±â¾÷Àº ¾îµðÀ̸ç, °ü·Ã¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
¼¼°è ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ°ú ¹Ì·¡ Àü¸ÁÀº?
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
½ÃÀå ¿ªÇÐ
ÃËÁø¿äÀÎ
¾ïÁ¦¿äÀÎ
±âȸ
°úÁ¦
ÁÖ¿ä µ¿Çâ
°Å½Ã°æÁ¦ ¿äÀÎ
¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
¼¼°èÀÇ ÇコÄɾî ÁöÃâ Àü¸Á
COVID-19ÀÇ ¿µÇ⠺м®
¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
Á¦3Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®
Á¦Ç° äÅà ºÐ¼®
¿ªÇÐ - ¿ù°æÅë
±â¼ú Æò°¡
±ÔÁ¦ »óȲ
¹ë·ùüÀÎ ºÐ¼®
À¯Åë ä³Î/¸¶ÄÏÇ÷¹À̽º ¸®½ºÆ®
ÃÖÁ¾»ç¿ëÀÚ ¸®½ºÆ®(¾÷°è)
ÁÖ¿ä °Å·¡¿Í ÇÕº´
PESTLE ºÐ¼®
Porter's Five Forces ºÐ¼®
Á¦4Àå °¡°Ý µ¿Ç⠺м®, 2019-2031³â
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
Á¦Ç° °¡°Ý¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
°¡°Ý ºÐ¼® : Á¦Ç° À¯Çüº°
Áö¿ªº° °¡°Ý°ú Á¦Ç° ¼±È£µµ
Á¦5Àå ¼¼°èÀÇ ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
¼¼°èÀÇ ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå Àü¸Á : Á¦Ç° À¯Çü
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, Á¦Ç° À¯Çüº°, 2019-2023³â
ÇöÀç ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Á¦Ç° À¯Çüº°, 2024-2031³â
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç° À¯Çü
¼¼°èÀÇ ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå Àü¸Á : ±â¼ú
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, ±â¼úº°, 2019-2023³â
ÇöÀç ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±â¼úº°, 2024-2031³â
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ±â¼ú
¼¼°èÀÇ ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå Àü¸Á : À¯Åë ä³Î
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, À¯Åë ä³Îº°, 2019-2023³â
ÇöÀç ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, À¯Åë ä³Îº°, 2024-2031³â
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : À¯Åë ä³Î
Á¦6Àå ¼¼°èÀÇ ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå Àü¸Á : Áö¿ª
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
°ú°Å ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼® : Áö¿ªº°, 2019-2023³â
ÇöÀç ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Áö¿ªº°, 2024-2031³â
ºÏ¹Ì
À¯·´
µ¿¾Æ½Ã¾Æ
³²¾Æ½Ã¾Æ¡¤¿À¼¼¾Æ´Ï¾Æ
¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ª
Á¦7Àå ºÏ¹ÌÀÇ ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
Á¦8Àå À¯·´ÀÇ ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
Á¦9Àå µ¿¾Æ½Ã¾ÆÀÇ ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
Á¦10Àå ³²¾Æ½Ã¾Æ¡¤¿À¼¼¾Æ´Ï¾ÆÀÇ ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿ù°æÅë ¿ÏÈ ±â±â ½ÃÀå Àü¸Á : ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2031³â)
Á¦13Àå °æÀï ±¸µµ
½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
½ÃÀå ±¸Á¶
°æÀï °ÝÈ ¸Ê : ½ÃÀ庰
°æÀï ´ë½Ãº¸µå
±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
Angelini Pharma Inc.
Ovira International
Welme
Myovant Sciences(Sumitovant Biopharma Ltd.)
Chiaro Technology Ltd(Elvie)
FemSense
±âŸ
Á¦14Àå ºÎ·Ï
Á¶»ç ¹æ¹ý
Á¶»çÀÇ ÀüÁ¦Á¶°Ç
µÎÀÚ¾î¿Í ¾à¾î
KSA
Persistence Market Research has recently released a comprehensive report on the global market for menstrual pain relief devices. This report provides a thorough assessment of critical market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.
Key Insights:
Menstrual Pain Relief Devices Market Size (2024E): US$10.5 Bn
Projected Market Value (2031F): US$18.8 Bn
Global Market Growth Rate (CAGR 2024 to 2031):8.6%
Menstrual Pain Relief Devices Market - Report Scope:
Menstrual pain relief devices are designed to alleviate discomfort associated with menstruation, offering various solutions ranging from heating pads and TENS (Transcutaneous Electrical Nerve Stimulation) units to wearable devices and innovative technology-based solutions. These devices are utilized in both home and clinical settings, catering to the needs of individuals suffering from dysmenorrhea and other menstrual-related pain conditions.
The market growth is driven by increasing awareness of menstrual health, rising demand for non-pharmacological pain management solutions, and advancements in device technology, which enhance user comfort and efficacy. The market caters to a wide demographic, including women of all ages experiencing menstrual pain, with a focus on improving quality of life and reducing reliance on medication.
Market Growth Drivers:
Several factors propel the global menstrual pain relief devices market, including growing consumer awareness about alternative pain relief methods, increasing incidence of menstrual pain among women, and the rising preference for non-invasive treatment options. The development of technologically advanced devices, such as smart heating pads and app-integrated TENS units, offers enhanced functionality and user experience, driving market expansion. Additionally, the increasing adoption of self-care and wellness products supports market growth, as more individuals seek personalized and convenient solutions for menstrual pain management.
Market Restraints:
Despite its promising growth prospects, the menstrual pain relief devices market faces challenges related to device affordability, consumer skepticism regarding efficacy, and limited awareness in some regions. The high cost of advanced menstrual pain relief devices may limit their accessibility, particularly in emerging markets with lower healthcare budgets. Furthermore, variations in consumer perceptions of device effectiveness and safety concerns could impact market adoption. Addressing these barriers requires targeted educational campaigns and efforts to improve device affordability and accessibility.
Market Opportunities:
The menstrual pain relief devices market presents significant growth opportunities driven by technological innovations, evolving consumer preferences, and expanding distribution channels. The integration of digital health technologies, such as mobile applications for pain tracking and personalized recommendations, enhances user engagement and treatment outcomes. Additionally, the increasing focus on female health and wellness provides opportunities for market players to introduce new and improved devices. Strategic investments in R&D, partnerships with healthcare providers, and expansion into new geographic regions are essential to capitalize on emerging opportunities and maintain market leadership.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the menstrual pain relief devices market globally?
Which device types and technologies are driving market adoption across different demographics?
How are technological advancements reshaping the competitive landscape of the menstrual pain relief devices market?
Who are the key players contributing to the menstrual pain relief devices market, and what strategies are they employing to stay relevant?
What are the emerging trends and future prospects in the global menstrual pain relief devices market?
Competitive Intelligence and Business Strategy:
Leading players in the global menstrual pain relief devices market, including companies such as Thermacare, TENSCare, and Flex, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced pain relief solutions, including wearable devices, smart heating pads, and app-connected TENS units. Collaborations with healthcare professionals, wellness centers, and retail outlets facilitate market access and promote technology adoption. Emphasis on clinical research, user feedback, and comprehensive marketing strategies helps enhance market presence and drive consumer trust.
Key Companies Profiled:
Angelini Pharma Inc.
Ovira International
Welme
Myovant Sciences (Sumitovant Biopharma Ltd.)
Chiaro Technology Ltd (Elvie)
FemSense
Matri
Menstrual Pain Relief Devices Market Segmentation
By Product Type
Wearable
Heating Pads
Portable Massagers
Others
By Technology
TENS Technology
Heat Therapy
Vibration Therapy
Ultrasound Therapy
Magnetic Therapy
Others
By Distribution Channel
Online Retail
Pharmacies
Supermarkets and Hypermarkets
Specialty Stores
Others
By Region
North America
Latin America
Europe
East Asia
Asia Pacific and Oceania
Middle East & Africa
Table of Contents
1. Executive Summary
1.1. Global Menstrual Pain Relief Devices Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global GDP Growth Outlook
2.3.2. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Epidemiology - Menstrual Pain
3.3. Technology Assessment
3.4. Regulatory Landscape
3.5. Value Chain Analysis
3.5.1. List of Distribution Channel/Marketplaces
3.5.2. List of End User (Industry)
3.6. Key Deals and Mergers
3.7. PESTLE Analysis
3.8. Porter's Five Force Analysis
4. Price Trend Analysis, 2019-2031
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product Type
4.4. Regional Prices and Product Preferences
5. Global Menstrual Pain Relief Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
5.1. Global Menstrual Pain Relief Devices Market Outlook: Product Type
5.1.1. Introduction / Key Findings
5.1.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2023
5.1.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
5.1.3.1. Wearable
5.1.3.2. Heating Pads
5.1.3.3. Portable Massagers
5.1.3.4. Others
5.2. Market Attractiveness Analysis: Product Type
5.3. Global Menstrual Pain Relief Devices Market Outlook: Technology
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019-2023
5.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2024-2031
5.3.3.1. TENS Technology
5.3.3.2. Heat Therapy
5.3.3.3. Vibration Therapy
5.3.3.4. Ultrasound Therapy
5.3.3.5. Magnetic Therapy
5.3.3.6. Others
5.4. Market Attractiveness Analysis: Technology
5.5. Global Menstrual Pain Relief Devices Market Outlook: Distribution Channel
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2023
5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2031
5.5.3.1. Online Retail
5.5.3.2. Pharmacies
5.5.3.3. Supermarkets and Hypermarkets
5.5.3.4. Specialty Stores
5.5.3.5. Others
5.6. Market Attractiveness Analysis: Distribution Channel
6. Global Menstrual Pain Relief Devices Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Menstrual Pain Relief Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
7.3.1. By Country
7.3.2. By Product Type
7.3.3. By Technology
7.3.4. By Distribution Channel
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
7.4.1. U.S.
7.4.2. Canada
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
7.5.1. Wearable
7.5.2. Heating Pads
7.5.3. Portable Massagers
7.5.4. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2024-2031
7.6.1. TENS Technology
7.6.2. Heat Therapy
7.6.3. Vibration Therapy
7.6.4. Ultrasound Therapy
7.6.5. Magnetic Therapy
7.6.6. Others
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2031
7.7.1. Online Retail
7.7.2. Pharmacies
7.7.3. Supermarkets and Hypermarkets
7.7.4. Specialty Stores
7.7.5. Others
7.8. Market Attractiveness Analysis
8. Europe Menstrual Pain Relief Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By Technology
8.3.4. By Distribution Channel
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
8.4.1. Germany
8.4.2. France
8.4.3. U.K.
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Turkey
8.4.8. Rest of Europe
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
8.5.1. Wearable
8.5.2. Heating Pads
8.5.3. Portable Massagers
8.5.4. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2024-2031
8.6.1. TENS Technology
8.6.2. Heat Therapy
8.6.3. Vibration Therapy
8.6.4. Ultrasound Therapy
8.6.5. Magnetic Therapy
8.6.6. Others
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2031
8.7.1. Online Retail
8.7.2. Pharmacies
8.7.3. Supermarkets and Hypermarkets
8.7.4. Specialty Stores
8.7.5. Others
8.8. Market Attractiveness Analysis
9. East Asia Menstrual Pain Relief Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Technology
9.3.4. By Distribution Channel
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
9.4.1. China
9.4.2. Japan
9.4.3. South Korea
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
9.5.1. Wearable
9.5.2. Heating Pads
9.5.3. Portable Massagers
9.5.4. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2024-2031
9.6.1. TENS Technology
9.6.2. Heat Therapy
9.6.3. Vibration Therapy
9.6.4. Ultrasound Therapy
9.6.5. Magnetic Therapy
9.6.6. Others
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2031
9.7.1. Online Retail
9.7.2. Pharmacies
9.7.3. Supermarkets and Hypermarkets
9.7.4. Specialty Stores
9.7.5. Others
9.8. Market Attractiveness Analysis
10. South Asia & Oceania Menstrual Pain Relief Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Technology
10.3.4. By Distribution Channel
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
10.4.1. India
10.4.2. Southeast Asia
10.4.3. ANZ
10.4.4. Rest of South Asia & Oceania
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
10.5.1. Wearable
10.5.2. Heating Pads
10.5.3. Portable Massagers
10.5.4. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2024-2031
10.6.1. TENS Technology
10.6.2. Heat Therapy
10.6.3. Vibration Therapy
10.6.4. Ultrasound Therapy
10.6.5. Magnetic Therapy
10.6.6. Others
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2031
10.7.1. Online Retail
10.7.2. Pharmacies
10.7.3. Supermarkets and Hypermarkets
10.7.4. Specialty Stores
10.7.5. Others
10.8. Market Attractiveness Analysis
11. Latin America Menstrual Pain Relief Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Technology
11.3.4. By Distribution Channel
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
11.5.1. Wearable
11.5.2. Heating Pads
11.5.3. Portable Massagers
11.5.4. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2024-2031
11.6.1. TENS Technology
11.6.2. Heat Therapy
11.6.3. Vibration Therapy
11.6.4. Ultrasound Therapy
11.6.5. Magnetic Therapy
11.6.6. Others
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2031
11.7.1. Online Retail
11.7.2. Pharmacies
11.7.3. Supermarkets and Hypermarkets
11.7.4. Specialty Stores
11.7.5. Others
11.8. Market Attractiveness Analysis
12. Middle East & Africa Menstrual Pain Relief Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
12.1. Key Highlights
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Technology
12.3.4. By Distribution Channel
12.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
12.4.1. GCC Countries
12.4.2. Egypt
12.4.3. South Africa
12.4.4. Northern Africa
12.4.5. Rest of Middle East & Africa
12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
12.5.1. Wearable
12.5.2. Heating Pads
12.5.3. Portable Massagers
12.5.4. Others
12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2024-2031
12.6.1. TENS Technology
12.6.2. Heat Therapy
12.6.3. Vibration Therapy
12.6.4. Ultrasound Therapy
12.6.5. Magnetic Therapy
12.6.6. Others
12.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024-2031
12.7.1. Online Retail
12.7.2. Pharmacies
12.7.3. Supermarkets and Hypermarkets
12.7.4. Specialty Stores
12.7.5. Others
12.8. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2024
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Angelini Pharma Inc.
13.3.1.1. Overview
13.3.1.2. Segments and Products
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Ovira International
13.3.3. Welme
13.3.4. Myovant Sciences (Sumitovant Biopharma Ltd.)
13.3.5. Chiaro Technology Ltd (Elvie)
13.3.6. FemSense
13.3.7. Others
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations